Chemoinformaics analysis of 2-Hydroxyfuranodiene
Molecular Weight | 232.323 | nRot | 0 |
Heavy Atom Molecular Weight | 212.163 | nRig | 14 |
Exact Molecular Weight | 232.146 | nRing | 2 |
Solubility: LogS | -4.344 | nHRing | 1 |
Solubility: LogP | 2.821 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
No. of Oxygen atom | 2 | No. of Arom Bond | 5 |
nHA | 2 | APOL | 39.9899 |
nHD | 1 | BPOL | 21.8001 |
QED | 0.696 |
Synth | 4.366 |
Natural Product Likeliness | 2.814 |
NR-PPAR-gamma | 0.244 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.012 |
Pgp-sub | 0.185 |
HIA | 0.558 |
CACO-2 | -4.636 |
MDCK | 0.0000235 |
BBB | 0.252 |
PPB | 0.921633 |
VDSS | 0.528 |
FU | 0.0297365 |
CYP1A2-inh | 0.229 |
CYP1A2-sub | 0.433 |
CYP2c19-inh | 0.438 |
CYP2c19-sub | 0.255 |
CYP2c9-inh | 0.198 |
CYP2c9-sub | 0.68 |
CYP2d6-inh | 0.064 |
CYP2d6-sub | 0.863 |
CYP3a4-inh | 0.102 |
CYP3a4-sub | 0.3 |
CL | 8.886 |
T12 | 0.634 |
hERG | 0.006 |
Ames | 0.016 |
ROA | 0.251 |
SkinSen | 0.248 |
Carcinogencity | 0.104 |
EI | 0.015 |
Respiratory | 0.678 |
NR-Aromatase | 0.037 |
Antiviral | Yes |
Prediction | 0.843442 |